Protocol Page


	Study ID (Protocol Number)
	CA184-178


	STUDY LOCATIONS*
	Childrens Hospital Of La Los Angeles, CA 90027 Recruiting	Dana-Farber Cancer Institute Boston, MA 02215 Recruiting
	Children's Hospital Of Orange County Orange, CA 92868 Recruiting	H. Lee Moffitt Cancer Center & Research Institute Tampa, FL 33612 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma
	STUDY OVERVIEW
	The purpose of the study is to comply with the Pediatric Investigation Plan requirements of Ipilimumab

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.